Noticias de REGN_US
Noticias del mercado
Últimas noticias sobre REGN_US — 563 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
If you are wondering whether Regeneron Pharmaceuticals at around US$766 per share still offers value, the answer depends on how you look at what the market is pricing in today. The stock recently closed at US$766.02, with returns of 2.7% over 7 days, 3.3% over 30 days, a 1.3% decline year to date, and 28.4% over the last year, which gives you a mixed snapshot of recent sentiment. Alongside these moves, investors have been tracking broader sector developments and company specific updates that...
Regeneron Partners with Trump Administration to Lower Drug Prices
El presidente Donald Trump anunciará un acuerdo de precios de medicamentos con la compañía farmacéutica Regeneron.
Regeneron Partners with Trump Administration to Lower Drug Prices
Regeneron Pharmaceuticals (REGN) Secures Pricing Deal with U.S. Government
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Regeneron to offer hearing-loss therapy for free after FDA nod
El presidente Donald Trump anunciará un acuerdo de precios de medicamentos con la compañía farmacéutica Regeneron.
Regeneron Pharmaceuticals (REGN) Receives FDA Accelerated Approval for Otarmeni
Regeneron to offer gene therapy free, align U.S. drug prices globally
Regeneron Pharmaceuticals (REGN) Receives FDA Accelerated Approval for Otarmeni
Regeneron proporcionará Otarmeni™ (lunsotogene parvec-cwha), su terapia génica recientemente aprobada para una forma ultrarara de pérdida auditiva genética, de forma gratuita en los EE. UU.
Y luego no hubo ninguno. | Cuando Regeneron anunció el jueves un acuerdo de fijación de precios de medicamentos con la Casa Blanca, las 17 empresas objetivo de una ronda de cartas de la administración Trump el año pasado acordaron seguir la estrategia de “nación más favorecida” del presidente.
Regeneron (REGN) Receives FDA Approval for Innovative Gene Thera
Regeneron Pharmaceuticals (REGN) Secures Pricing Deal with U.S. Government
Página 22 de 29
